We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$96.1B
AUM Growth
-$20.7B
Cap. Flow
-$1.83B
Cap. Flow %
-1.91%
Top 10 Hldgs %
18.42%
Holding
4,634
New
1,015
Increased
1,221
Reduced
1,970
Closed
108

Top Sells

Rank Stock Value
1
FXI icon
iShares China Large-Cap ETF
FXI
+$256M
2
C icon
Citigroup
C
+$159M
3
PCG icon
PG&E
PCG
+$138M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$132M
5
UBS icon
UBS Group
UBS
+$113M

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 16.32%
3 Financials 13.63%
4 Consumer Discretionary 9.13%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARL icon
3751
American Realty Investors
ARL
$246M
$0 ﹤0.01%
+7
New +$132
ARTNA icon
3752
Artesian Resources
ARTNA
$354M
$0 ﹤0.01%
+8
New +$376
ASC icon
3753
Ardmore Shipping
ASC
$699M
$0 ﹤0.01%
+67
New +$448
ASND icon
3754
Ascendis Pharma A/S
ASND
$16.5B
-5,900
Closed -$692K
ATER icon
3755
Aterian
ATER
$5.48M
$0 ﹤0.01%
+4
New +$177
LONA
3756
LeonaBio Inc
LONA
$71.6M
$0 ﹤0.01%
+3
New +$275
ATNM icon
3757
Actinium Pharmaceuticals
ATNM
$23.8M
$0 ﹤0.01%
+1
New +$6
ATOM icon
3758
Atomera
ATOM
$204M
$0 ﹤0.01%
+21
New +$231
ATRO icon
3759
Astronics
ATRO
$3.93B
$0 ﹤0.01%
+34
New +$307
AURA icon
3760
Aura Biosciences
AURA
$766M
$0 ﹤0.01%
+12
New +$199
AVNW icon
3761
Aviat Networks
AVNW
$273M
$0 ﹤0.01%
+11
New +$318
JBIO
3762
Jade Biosciences
JBIO
$1.35B
0
AVTX icon
3763
Avalo Therapeutics
AVTX
$992M
0
AXDX
3764
DELISTED
Accelerate Diagnostics
AXDX
-4,015
Closed -$57K
AXGN icon
3765
Axogen
AXGN
$2.43B
-37,890
Closed -$301K
AXTI icon
3766
AXT Inc
AXTI
$4.57B
$0 ﹤0.01%
+46
New +$271
BATL icon
3767
Battalion Oil
BATL
$28.8M
$0 ﹤0.01%
+12
New +$193
BBCP icon
3768
Concrete Pumping Holdings
BBCP
$496M
$0 ﹤0.01%
+27
New +$153
BBU
3769
DELISTED
Brookfield Business Partners
BBU
-318,533
Closed -$9.79M
BBW icon
3770
Build-A-Bear
BBW
$432M
$0 ﹤0.01%
+7
New +$128
BCAB icon
3771
BioAtla
BCAB
$5.81M
-259
Closed -$41.2K
BCBP icon
3772
BCB Bancorp
BCBP
$161M
$0 ﹤0.01%
+7
New +$130
BCML icon
3773
BayCom
BCML
$331M
$0 ﹤0.01%
+9
New +$198
BDSX icon
3774
Biodesix
BDSX
$258M
0
BDTX icon
3775
Black Diamond Therapeutics
BDTX
$107M
$0 ﹤0.01%
+12
New +$28

Similar funds

Credit Suisse's Q2 2022 Portfolio in Review

As of Q2 2022, Credit Suisse held 4,634 positions worth $96.1B, down 18% from $117B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Credit Suisse's Q2 2022 filing shows 1,015 new, 1,221 increased, 1,970 reduced and 108 closed positions. Its largest new stake was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M. The largest sale was iShares China Large-Cap ETF, an estimated $256M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q2 2022 buy was iShares U.S. Carbon Transition Readiness Aware Active ETF: 990,000 shares worth $41.3M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $278M increase.
  • Credit Suisse's biggest Q2 2022 reduction was iShares China Large-Cap ETF, cutting an estimated $256M.
  • Credit Suisse fully exited Cerner Corp in Q2 2022, selling an estimated $46M.
  • Credit Suisse's ten largest holdings make up 18% of its $96.1B portfolio in Q2 2022.
  • Credit Suisse opened 1,015 new positions and closed 108 in Q2 2022.
  • Credit Suisse's portfolio value fell 18% quarter-over-quarter to $96.1B.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.